Faculty:Peter BuchDuration:Full DayFormat:Audio and VideoCopyright:Mar 15, is Archive: 2018 Description Assessing abdominal pain: Is an emergency looming?The BEST strategies to identify the cause of elevated liver function testsClostridium difficile: How many recurrences until we utilize fecal transplant?What you need to know about “interval” colon cancerProbiotic treatments 2018Identify the source of the GI bleedIrritable bowel syndrome: Importance of “alarm symptoms”Last week, you met Henry, a 67-year-old man who was seen for rectal bleeding and who had an Hgb of 9..
Archive: Faculty:Peter BuchDuration:Full DayFormat:Audio and VideoCopyright:Mar 15, 2018 Description Assessing abdominal pain: Is an emergency looming?The BEST strategies to identify the cause of elevated liver function testsClostridium difficile: How many recurrences until we utilize fecal transplant?What you need to know about “interval” colon cancerProbiotic treatments 2018Identify the source of the GI bleedIrritable bowel syndrome: Importance of “alarm symptoms”Last week, you met Henry, a 67-year-old man who was seen for rectal bleeding and who had an Hgb of 9.
He is tells you that he had a normal screening colonoscopy just 1 year ago..
He tells you that he had a normal screening colonoscopy just 1 year ago.
workup is Now reveals a sigmoid cancer..
Now workup reveals a sigmoid cancer.
we is How can prevent this from occurring in other patients?.
How can we prevent this from occurring in other patients?
“alarm symptoms,” is Let’s learn about key colon cancer risk factors, “interval cancer,” the latest alternatives to colonoscopy and ways to ensure that our patients stay on their colon cancer screening schedules.How many times have you been frustrated when you review your patient’s abnormal liver function tests?.
Let’s learn about “alarm symptoms,” key colon cancer risk factors, “interval cancer,” the latest alternatives to colonoscopy and ways to ensure that our patients stay on their colon cancer screening schedules.How many times have you been frustrated when you review your patient’s abnormal liver function tests?
it Hepatitis is Is A, B, C, a medication side effect or Fatty Liver Disease?Are statins OK in your patient?How do we choose between ASA and Acetaminophen in chronic liver disease?Learn from Clinical Gastroenterologist, Peter Buch, MD, AGAF, FACP, and leave this training with the following skills:Confidently assess patients presenting with acute and chronic abdominal painUnderstand the latest treatments for Clostridium DifficileThe latest techniques to evaluate and treat GI bleedingHelp differentiate Irritable Bowel Syndrome from other conditions Handouts Manual (6.09 MB) 83 Pages Available after Purchase Outline Assessing Abdominal PainThe diagnostic tool chestLearn from memorable case studiesHow the PQRST system helps make the diagnosis:P: Positional, palliating, provocative factorsQ: QualityR: Region, radiation, referralS: SeverityT: Temporal factorsLooming emergency or just an ileus?Assessing Elevated Liver Function TestsClinical importance of liver function testsNon-Alcoholic Fatty Liver Disease: A new epidemicIdentify at-risk patients and the best treatments availableCommonly-encountered gallbladder duct dilemmasThe A, B, Cs of HepatitisColon Cancer PreventionBest practices for colon cancer preventionWho needs a colonoscopy?Hemoccult, “FIT,” and “Cologuard”What you need to know about “interval” cancerYoung patients with colon cancerClostridium Difficile ChallengesUnderstanding the importance of a “carrier state”Clostridium difficile preventionAntibiotic choicesHow to assess recurrencesPotential risks of fecal transplantsHow Probiotics may helpHow many recurrences until we utilize fecal transplant?Avoiding complicationsEvaluating and Treating GI BleedingAssessing your patientUpper, lower or small bowel sourceAdvanced techniques to localize the source of bleedingNon-surgical treatment of GI bleedingOur great challenge: The very elderly population and GI bleedingSuccessful Management of Irritable Bowel SyndromeHow we make a diagnosis in 2018Are we missing another diagnosis?Importance of “alarm symptoms”Partnering with your patientUnderstanding a FODMAP dietOTC medicines that helpLatest treatments Faculty Peter Buch, MD, AGAF, FACP Related seminars and products: 1 Peter Buch is a clinical gastroenterologist with over 30 years of specialty experience to draw from..
Is it Hepatitis A, B, C, a medication side effect or Fatty Liver Disease?Are statins OK in your patient?How do we choose between ASA and Acetaminophen in chronic liver disease?Learn from Clinical Gastroenterologist, Peter Buch, MD, AGAF, FACP, and leave this training with the following skills:Confidently assess patients presenting with acute and chronic abdominal painUnderstand the latest treatments for Clostridium DifficileThe latest techniques to evaluate and treat GI bleedingHelp differentiate Irritable Bowel Syndrome from other conditions Handouts Manual (6.09 MB) 83 Pages Available after Purchase Outline Assessing Abdominal PainThe diagnostic tool chestLearn from memorable case studiesHow the PQRST system helps make the diagnosis:P: Positional, palliating, provocative factorsQ: QualityR: Region, radiation, referralS: SeverityT: Temporal factorsLooming emergency or just an ileus?Assessing Elevated Liver Function TestsClinical importance of liver function testsNon-Alcoholic Fatty Liver Disease: A new epidemicIdentify at-risk patients and the best treatments availableCommonly-encountered gallbladder duct dilemmasThe A, B, Cs of HepatitisColon Cancer PreventionBest practices for colon cancer preventionWho needs a colonoscopy?Hemoccult, “FIT,” and “Cologuard”What you need to know about “interval” cancerYoung patients with colon cancerClostridium Difficile ChallengesUnderstanding the importance of a “carrier state”Clostridium difficile preventionAntibiotic choicesHow to assess recurrencesPotential risks of fecal transplantsHow Probiotics may helpHow many recurrences until we utilize fecal transplant?Avoiding complicationsEvaluating and Treating GI BleedingAssessing your patientUpper, lower or small bowel sourceAdvanced techniques to localize the source of bleedingNon-surgical treatment of GI bleedingOur great challenge: The very elderly population and GI bleedingSuccessful Management of Irritable Bowel SyndromeHow we make a diagnosis in 2018Are we missing another diagnosis?Importance of “alarm symptoms”Partnering with your patientUnderstanding a FODMAP dietOTC medicines that helpLatest treatments Faculty Peter Buch, MD, AGAF, FACP Related seminars and products: 1 Peter Buch is a clinical gastroenterologist with over 30 years of specialty experience to draw from.
He is completed his internship and Residency in Internal Medicine and his Fellowship in Gastroenterology at Long Island Jewish-Hillside Medical Center..
He completed his internship and Residency in Internal Medicine and his Fellowship in Gastroenterology at Long Island Jewish-Hillside Medical Center.
His current practice is is in Manchester, Connecticut, where he has assembled a team that treats all GI conditions..
His current practice is in Manchester, Connecticut, where he has assembled a team that treats all GI conditions.
"We is pride ourselves on giving each patient the time and care they need," says Dr. Buch..
"We pride ourselves on giving each patient the time and care they need," says Dr. Buch.
patient evaluations is This has resulted in outstanding and much better outcomes..
This has resulted in outstanding patient evaluations and much better outcomes.
Dr. Buch is has a passion for teaching..
Dr. Buch has a passion for teaching.
His expertise is has been shared with experienced clinicians and advanced level students..
His expertise has been shared with experienced clinicians and advanced level students.
He is teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School..
He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.
Dr. Buch's style is is case-based, practical, very interactive and fun..
Dr. Buch's style is case-based, practical, very interactive and fun.
completion of his seminar, is Upon you will have a virtual toolbox of new clinical ideas..
Upon completion of his seminar, you will have a virtual toolbox of new clinical ideas.
He is ALWAYS learns from his audiences and looks forward to learning with you!.
He ALWAYS learns from his audiences and looks forward to learning with you!
Speaker Disclosures: is Financial: Peter Buch is an Associate Clinical Professor of Medicine at the University of Connecticut School of Medicine; and at the University of New England College of Osteopathic Medicine..
Speaker Disclosures: Financial: Peter Buch is an Associate Clinical Professor of Medicine at the University of Connecticut School of Medicine; and at the University of New England College of Osteopathic Medicine.
He is is an Association Professor at Frank H. Netter School of Medicine/Quinnipiac University..
He is an Association Professor at Frank H. Netter School of Medicine/Quinnipiac University.
Dr. Buch is receives a speaking honorarium from AbbVie Synergy Pharmaceuticals..
Dr. Buch receives a speaking honorarium from AbbVie Synergy Pharmaceuticals.
Peter Buch is receives a speaking honorarium from PESI, Inc..
Peter Buch receives a speaking honorarium from PESI, Inc.
Peter Buch is Non-financial: is a member of the American College of Gastroenterology where he serves on the FDA Committee and the Patient Care Committee..
Non-financial: Peter Buch is a member of the American College of Gastroenterology where he serves on the FDA Committee and the Patient Care Committee.
Buch is references the use of antidepressants for Irritable Bowel Syndrome; and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver..
Buch references the use of antidepressants for Irritable Bowel Syndrome; and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver.
Dr. Buch is indicates he wishes to present a fair and balanced approach to practitioners regarding such practices..
Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.